Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
Motley Fool
Thu, 05/7/20 - 10:46 am
FDA
drug approvals
Gilead Sciences
remdesivir
AstraZeneca
Merck
Lynparza
Clovis Oncology
Rubraca
Bristol-Myers Squibb
Opdivo
Yervoy
Go or no go? Oncology dominates upcoming decisions
EP Vantage
Fri, 05/1/20 - 11:09 am
FDA
oncology
AstraZeneca
Lynparza
ovarian cancer
prostate cancer
Bristol-Myers Squibb
Opdivo
lung cancer
Exelixis lands PhIII kidney cancer win with Bristol Myers in their hunt for $4 billion
Endpoints
Mon, 04/20/20 - 11:59 pm
Bristol-Myers Squibb
Opdivo
Exelixis
Cabometyx
renal cell carcinoma
kidney cancer
clinical trials
BMS' Opdivo gets another lung cancer shot as FDA, EMA accept chemo combo filings
Fierce Pharma
Wed, 04/8/20 - 11:40 pm
Bristol-Myers Squibb
Opdivo
Yervoy
non-small cell lung cancer
FDA
Europe
priority review
EMA
Bristol Myers Squibb snags new liver cancer nod for Opdivo-Yervoy combo
Fierce Pharma
Wed, 03/11/20 - 12:58 pm
Bristol-Myers Squibb
Opdivo
Yervoy
FDA
liver cancer
hepatocellular carcinoma
A Big Month Ahead for the FDA and Bristol-Myers Squibb
Motley Fool
Sat, 02/22/20 - 11:39 pm
Bristol-Myers Squibb
Celgene
FDA
ozanimod
Opdivo
Reblozyl
Five Prime Therapeutics’ pancreatic cancer combo with Opdivo a bust
Fierce Biotech
Tue, 02/18/20 - 08:29 pm
Five Prime Therapeutics
cabiralizumab
Bristol-Myers Squibb
Opdivo
pancreatic cancer
Opdivo delivers superior five-year survival results in renal cell carcinoma
Pharmaceutical Business Review
Mon, 02/17/20 - 10:33 am
Bristol-Myers Squibb
Opdivo
clinical trials
renal cell carcinoma
Bristol-Myers Withdraws European Application for Lung Cancer Combo
Motley Fool
Sun, 02/2/20 - 11:51 pm
Bristol-Myers Squibb
Europe
Opdivo
Yervoy
non-small cell lung cancer
Vedanta Biosciences initiates first-in-patient study of VE800 in combination with Bristol-Myers Squibb’s Opdivo
Pharmaceutical Business Review
Wed, 12/11/19 - 10:10 am
Vedanta Biosciences
VE800
Bristol-Myers Squibb
Opdivo
cancer
clinical trials
Bristol-Myers misses main goal of late-stage skin cancer trial
Yahoo/Reuters
Wed, 11/20/19 - 09:50 am
Bristol-Myers Squibb
clinical trials
Yervoy
Opdivo
advanced melanoma
Breakthrough status and promise of a speedy review arrives for Opdivo/Yervoy combination as Bristol-Myers bites at Bayer
Endpoints
Mon, 11/11/19 - 11:06 am
Bristol-Myers Squibb
Opdivo
liver cancer
Yervoy
FDA
Nektar shows durability of Opdivo combo in 18-month update
Fierce Biotech
Mon, 11/11/19 - 10:53 am
Nektar Therapeutics
NKTR-214
Opdivo
Bristol-Myers Squibb
melanoma
clinical trials
Should Merck Investors Worry About Bristol Myers' Lung Cancer Drug Results?
Motley Fool
Mon, 11/4/19 - 10:23 am
Merck
Bristol-Myers Squibb
Yervoy
Opdivo
Keytruda
lung cancer
Bristol-Myers warns I-O blockbuster Opdivo will be 'under pressure' in 2020
Fierce Pharma
Thu, 10/31/19 - 11:52 pm
Bristol-Myers Squibb
Opdivo
Keytruda
Merck
Bristol-Myers makes Opdivo pitch for frontline lung cancer with open label PhIII study
Endpoints
Tue, 10/22/19 - 10:39 am
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
advanced non-small cell lung cancer
clinical trials
Mike Quigley has personal motivation leading oncology at Bristol-Myers Squibb
Bizjournals
Sat, 09/21/19 - 12:35 pm
Mike Quigley
oncology
Bristol-Myers Squibb
Opdivo
Yervoy
cancer immunotherapy
The top drugs facing cuts under Pelosi's pricing plan
Biopharma Dive
Fri, 09/20/19 - 10:46 pm
drug pricing
Nancy Pelosi
regulatory
Revlimid
Keytruda
Opdivo
Januvia
insulin
Medicare
Bristol-Myers' (BMY) Opdivo Falls Flat in Brain Tumor Study
Yahoo/Zacks.com
Sat, 09/7/19 - 06:18 pm
Bristol-Myers Squibb
Opdivo
glioblastoma
Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint
Endpoints
Thu, 09/5/19 - 10:13 am
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »